ASX:RVA

REVA Medical Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive RVA News and Ratings via Email

Sign-up to receive the latest news and ratings for REVA Medical and its competitors with MarketBeat's FREE daily newsletter.

About REVA Medical

REVA Medical, Inc., a medical device company, focuses on the development and commercialization of polymer-based bioresorbable products for vascular applications. The company offers Fantom Encore, a bioresorbable vascular scaffold for the treatment of coronary artery disease; and MOTIV bioresorbable vascular scaffold for the treatment of below-the-knee peripheral artery disease. It sells Fantom Encore in Germany, Switzerland, Austria, the Netherlands, Belgium, Luxembourg, Italy, and Turkey. The company was formerly known as MD3, Inc. and changed its name to REVA Medical, Inc. in March 2002. REVA Medical, Inc. was founded in 1998 and is headquartered in San Diego, California.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolASX:RVA
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.teamreva.com
Phone+1-858-9663000
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.88 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for REVA Medical.

4.4 Community Rank

Outperform Votes
REVA Medical has received 40 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
REVA Medical has received 20 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
REVA Medical has received 66.67% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about REVA Medical and other stocks. Vote “Outperform” if you believe RVA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RVA will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
REVA Medical does not currently pay a dividend.
Dividend Growth
REVA Medical does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, REVA Medical insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

REVA Medical (ASX:RVA) Frequently Asked Questions

What stocks does MarketBeat like better than REVA Medical?: Wall Street analysts have given REVA Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but REVA Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
How were REVA Medical's earnings last quarter?: REVA Medical Inc (ASX:RVA) announced its earnings results on Tuesday, August, 7th. The company reported $0.61 earnings per share for the quarter.
View REVA Medical's earnings history.
Who are REVA Medical's key executives?: REVA Medical's management team includes the following people:
Ms. Regina E. Groves, CEO & Director (Age 61)
Mr. Robert B. Stockman, Co-Founder & Director (Age 65)
Mr. Jeffrey A. Anderson, Sr. VP of Clinical & Regulatory Affairs (Age 52)
Ms. Leigh F. Elkolli, CFO, Principal Accounting Officer, Corp. Sec. & Corp. Controller (Age 47)
Ms. Jessica Earley, VP of Operations & Product Devel.
Who are some of REVA Medical's key competitors?: Some companies that are related to REVA Medical include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH) and Cochlear (CHEOY).
View all of RVA's competitors.
What is REVA Medical's stock symbol?: REVA Medical trades on the ASX under the ticker symbol "RVA."
How much money does REVA Medical make?: REVA Medical has a market capitalization of $0.00.
What is REVA Medical's official website?: The official website for REVA Medical is www.teamreva.com.
Where are REVA Medical's headquarters?: REVA Medical is headquartered at 5751 Copley Dr, SAN DIEGO, CA 92111-7911, United States.
How can I contact REVA Medical?: REVA Medical's mailing address is 5751 Copley Dr, SAN DIEGO, CA 92111-7911, United States. The company can be reached via phone at +1-858-9663000.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.